ClinicalTrials.gg

Program

omecamtiv mecarbil

Also written as “CK-1827452”, “Omecamtiv mecarbil” and “Omecamtiv Mecarbil (OM)”.

Its studies are mostly in Heart Failure · Ventricular Dysfunction, Left, led by Cytokinetics.

Furthest: phase 3, since Sep 30, 201616 company-led studies, 1 open or runningNext primary completion: Sep 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Cytokinetics161 open or runningphase 3since Sep 30, 2016Dec 21, 2007Sep 2027phase 3 · NCT06736574

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 2 studies since Dec 21, 2007.

  1. May 20, 2008Phase 2 study in Heart FailureNCT00682565 · 94 enrolled · Georgia, Russian Federation
  2. Jul 15, 2009Phase 2 study in Heart FailureNCT00941681 · 35 enrolled · Georgia
  3. Feb 25, 2010Phase 2 study in Heart FailureNCT01077167
  4. Feb 17, 2011Phase 2 study in Heart FailureNCT01300013 · 614 enrolled · United States, Australia, Belgium and more
  5. Jun 22, 2011Phase 1 study in Heart FailureNCT01380223 · 35 enrolled · United Kingdom
  6. Oct 16, 2012Phase 1 study in Heart FailureNCT01737866 · 13 enrolled · United States
  7. Jan 18, 2013Phase 2 study in Ventricular Dysfunction, LeftNCT01786512 · 544 enrolled · United States, Australia, Belgium and more
  8. Jun 17, 2015Phase 1 study in Heart FailureNCT02601001 · 50 enrolled · Japan
  9. Feb 25, 2016Phase 2 study in Heart FailureNCT02695420 · 81 enrolled · Japan
  10. Sep 30, 2016Phase 3 study in Heart FailureNCT02929329 · 8,256 enrolled · United States, Argentina, Australia and more
  11. Nov 15, 2018Phase 3 study in Heart Failure With Reduced Ejection FractionNCT03759392 · 276 enrolled · United States, Canada, France and more
  12. Nov 7, 2019Phase 1 study in QT Intervals ChangesNCT04175808 · 70 enrolled · United Kingdom
  13. Jul 6, 2020Phase 3 study in Chronic Heart Failure With Reduced Ejection FractionNCT04464525
  14. Dec 3, 2024Phase 3 study in Heart FailureNCT06736574 · 1,800 planned · United States, Canada, China and more

Ahead

  1. Sep 2027Primary completion: phase 3 study in Heart FailureNCT06736574

TargetBeta

“Cardiac myosin activator”ChEMBL 37, by rule

Other programs on the same 7 targets

ProgramCompanyFurthest phaseStudies
mavacamtenruleBristol-Myers Squibbphase 420
danicamtivruleBristol-Myers Squibbphase 37

Studies

All 16 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06736574Heart Failure · United States, Canada, China and more3RecruitingSep 20271,800
NCT04464525Chronic Heart Failure With Reduced Ejection Fraction3WithdrawnNov 27, 20260
NCT04175808QT Intervals Changes · United Kingdom1CompletedMar 4, 202070
NCT03759392Heart Failure With Reduced Ejection Fraction · United States, Canada, France and more3CompletedNov 8, 2021276
NCT02929329Heart Failure · United States, Argentina, Australia and more3CompletedSep 14, 20208,256
NCT02695420Heart Failure · Japan2CompletedApr 6, 201781
NCT02601001Heart Failure · Japan1CompletedJan 6, 201650
NCT01786512Ventricular Dysfunction, Left · United States, Australia, Belgium and more2CompletedJul 22, 2015544
NCT01737866Heart Failure · United States1CompletedJan 201313
NCT01380223Heart Failure · United Kingdom1CompletedApr 200635
NCT01300013Heart Failure · United States, Australia, Belgium and more2CompletedApr 2013614
NCT01077167Heart Failure2WithdrawnMay 20110
NCT00941681Heart Failure · Georgia2CompletedOct 200935
NCT00682565Heart Failure · Georgia, Russian Federation2CompletedNov 200894
NCT00748579Heart Failure · United States, Canada2TerminatedNov 20082
NCT00624442Heart Failure · United States, Georgia, Russian Federation and more2CompletedFeb 200945

How it is read

Names in the registry

  • “CK-1827452”, 18 entries
  • “omecamtiv mecarbil”, 10 entries
  • “Omecamtiv mecarbil”, 4 entries
  • “Omecamtiv Mecarbil (OM)”, 2 entries
  • “Omecamtiv Mecarbil”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.